44 results
8-K
EX-10.1
AXLA
Axcella Health Inc.
17 Feb 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.2
AXLA
Axcella Health Inc.
17 Feb 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.3
AXLA
Axcella Health Inc.
17 Feb 23
Departure of Directors or Certain Officers
5:17pm
10-Q
2022 Q3
EX-10.2
AXLA
Axcella Health Inc.
Quarterly report
1 Nov 22
4:13pm
8-K
EX-10.1
AXLA
Axcella Health Inc.
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
8-K
EX-10.2
1j1nwdhcyf
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
hsrdkzb
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
vkehanmqesztld
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
8-K
EX-10.1
0x2si8 3r63l15h1snn
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-10.1
s189sqr 1i5b1urrj
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-10.1
jn02z21ftj0f3 1j2i7
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-10.1
67qo5mnjt3g2us
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-10.1
izcrc80zfllup7 rc6g
31 Aug 20
Entry into a Material Definitive Agreement
9:00am